2016;39:105-16. SELLAS Life Sciences Group Galinpepimut -S Protocol : SLS17 -201/ MK3475 -770 Protocol v1.1 (Amendment 1.0) 12 April 2019 Page 242 Joeckel TE, Lübbert M. Clinical results with the DNA hypomethylating agent 5 -aza-2'- deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update. Se min Hematol.